Diabetes Feature Archive

Addressing Psychological Insulin Resistance in Patients With Diabetes

Addressing Psychological Insulin Resistance in Patients With Diabetes

Learn about strategies to reduce a patient's reluctance to initiate insulin therapy, a phenomenon called psychological insulin resistance.

Managing Osteoporosis With Type 2 Diabetes: An Expert Opinion

Managing Osteoporosis With Type 2 Diabetes: An Expert Opinion

Researchers conducted a systematic review of available literature to create a guide for optimal management of patients with type 2 diabetes and osteoporosis.

Management of Hypoglycemia: Insulin Degludec vs Insulin Glargine

Management of Hypoglycemia: Insulin Degludec vs Insulin Glargine

Expert Q&A compares the effects of insulin degludec and insulin glargine U100 in patients with type 1 and type 2 diabetes.

Hepatitis C Virus: An Increased Risk For Type 2 Diabetes

Hepatitis C Virus: An Increased Risk For Type 2 Diabetes

Type 2 diabetes risk appears to be increased in patients with hepatitis C virus and related disorders.

Type 2 Diabetes Therapy Intensification: Part II: GLP-1 Agonist Adverse Effects and Fixed-Ratio Combinations

Type 2 Diabetes Therapy Intensification: Part II: GLP-1 Agonist Adverse Effects and Fixed-Ratio Combinations

When basal insulin no longer provides adequate glucose control in type 2 diabetes, a rapid-acting insulin or a glucagon-like peptide-1 receptor agonist may be used to intensify therapy.

Type 2 Diabetes Therapy Intensification: Part I: Insulin vs GLP-1 Agonists

Type 2 Diabetes Therapy Intensification: Part I: Insulin vs GLP-1 Agonists

When basal insulin no longer provides adequate glucose control in type 2 diabetes, a rapid-acting insulin or a glucagon-like peptide-1 receptor agonist may be used to intensify therapy.

A Clinician's Plea for More Pragmatic Clinical Trials in Diabetes

A Clinician's Plea for More Pragmatic Clinical Trials in Diabetes

Studies designed to address real-world challenges can potentially lead to both better-informed clinical decision making and improved outcomes.

Preoperative Glargine Dosing May Affect Perioperative Glycemic Control

Preoperative Glargine Dosing May Affect Perioperative Glycemic Control

Patients who received 60% to 87% of the normal evening glargine dose had the highest likelihood of achieving glycemic control.

Using Analogies in Endocrinology to Better Care for Patients

Using Analogies in Endocrinology to Better Care for Patients

An endocrinologist discusses the value of using everyday analogies to explain diabetes management issues to his patients.

Rising Insulin Prices: ADA & Endocrine Society Call for Action

Rising Insulin Prices: ADA & Endocrine Society Call for Action

The American Diabetes Association and the Endocrine Society have issued statements with the intent of improving insulin access and affordability.

Diabetes Psychosocial Care Addressed by ADA in First Published Recommendations

Diabetes Psychosocial Care Addressed by ADA in First Published Recommendations

Evidence-based guidelines and clinician recommendations have been evaluated to create the first-of-its-kind statement focused on psychosocial care of people with diabetes.

Case Study: Combination GLP-1/DPP-4 Therapy in Type 2 Diabetes

Case Study: Combination GLP-1/DPP-4 Therapy in Type 2 Diabetes

The use of combined GLP-1/DPP-4 medication therapy is not currently supported by American Diabetes Association guidelines.

Diabetic Neuropathy: Updated ADA Position Statement

Diabetic Neuropathy: Updated ADA Position Statement

The ADA updated recommendations on prevention methods and pain management for 2 forms of diabetic neuropathy.

ADA Releases 2017 Standards of Medical Care in Diabetes

ADA Releases 2017 Standards of Medical Care in Diabetes

The American Diabetes Association 2017 Standards of Medical Care in Diabetes addresses important new issues in diabetes care, including metabolic surgery and a more specific definition of hypoglycemia.

How Can We Use the "Wow" Factor to Improve Patient Care?

How Can We Use the "Wow" Factor to Improve Patient Care?

The natural curiosity provoked by looking at research and clinical care with a sense of wonder may help us find new ways to deal with old problems.

New Recommendation on Reporting Hypoglycemia in Clinical Trials

New Recommendation on Reporting Hypoglycemia in Clinical Trials

Two diabetes associations are calling for more standard definitions of hypoglycemia to improve information on risk garnered during clinical trials.

VARIATION Study: Investigator Insights

VARIATION Study: Investigator Insights

Harpreet Bajaj, MD, MPH, ECNU, FACE, offers perspective on his study of various insulin regimens in type 2 diabetes.

Diabetic Peripheral Neuropathy: Diagnosis and Treatment

Diabetic Peripheral Neuropathy: Diagnosis and Treatment

Often underreported and undertreated, outcomes can be improved in this condition with appropriate screening and diagnosis.

Updated ADA Guidelines on Physical Activity for People With Diabetes

Updated ADA Guidelines on Physical Activity for People With Diabetes

The American Diabetes Association has updated its guidelines and physical activity for patients with type 1 diabetes, type 2 diabetes, and prediabetes.

Optimal Diabetes Management: What's Stopping Your Patients?

Optimal Diabetes Management: What's Stopping Your Patients?

In addition to financial and time barriers, patients encounter an array of problems that interfere with their achieving optimal control of their diabetes.

Lifestyle Changes: Great Intentions...

Lifestyle Changes: Great Intentions...

Several strategies may help patients incorporate lifestyle changes into their daily lives.

New Recommendations Address Use of Diabetes Technology

New Recommendations Address Use of Diabetes Technology

The Endocrine Society has issued a clinical practice guideline with recommendations regarding the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in diabetes.

Polypharmacy and Lipid Profiles in Type 2 Diabetes

Polypharmacy and Lipid Profiles in Type 2 Diabetes

Even if the impact of a given medication on lipid profile is relatively minimal, and therefore unlikely to independently affect ASCVD risk, the cumulative effect is important and cannot be overlooked.

Physical Activity and Type 2 Diabetes: When and How Much?

Physical Activity and Type 2 Diabetes: When and How Much?

Both the timing and amount of physical activity are important in risk reduction and management of type 2 diabetes.

Some Rheumatoid Arthritis Drugs Beneficial in Diabetes

Some Rheumatoid Arthritis Drugs Beneficial in Diabetes

Research has shown that rheumatologic disease and diabetes frequently go hand-in-hand.

SUSTAIN-6: Cardiovascular Safety of Semaglutide in Type 2 Diabetes

SUSTAIN-6: Cardiovascular Safety of Semaglutide in Type 2 Diabetes

Researchers found the cardiovascular safety of semaglutide was noninferior to placebo in high-risk patients with type 2 diabetes.

How Do We Use Technology for Diabetes Management?

How Do We Use Technology for Diabetes Management?

Edward C. Chao, DO, highlights important considerations for developing technology for diabetes management.

Managing Pregestational Diabetes in Pregnancy

Managing Pregestational Diabetes in Pregnancy

Planning is essential to preventing risks to the mother and fetus.

Implementing Diabetes Self-Management Education in Type 2 Diabetes

Implementing Diabetes Self-Management Education in Type 2 Diabetes

Joan K. Bardsley, MBA, RN, CDE, describes a joint position statement regarding implementation of diabetes self-management education.

Role of the Gut Microbiome in Diabetes

Role of the Gut Microbiome in Diabetes

Research shows that further understanding of the gut microbiome may improve diagnosis, prevention, and treatment of the disease earlier in life.

Putting the Pedal to the Metal: Igniting and Sustaining Adherence

Putting the Pedal to the Metal: Igniting and Sustaining Adherence

What tools or techniques can we offer our patients to facilitate starting and sustaining adherence?

Preventing Diabetes and Complications: What Are the Challenges?

Preventing Diabetes and Complications: What Are the Challenges?

A change in how patients and physicians view diabetes may is necessary for preventing the disease and its complications.

Closing the Gap: Can Our Toughest Patients Be Our Greatest Teachers?

Closing the Gap: Can Our Toughest Patients Be Our Greatest Teachers?

Sometimes the most frustrating patients, the so-called "non-adherent" ones, can teach us how to improve diabetes care.

FDA Advisory Committee Supports Lixisenatide and Insulin Glargine for Type 2 Diabetes Management

FDA Advisory Committee Supports Lixisenatide and Insulin Glargine for Type 2 Diabetes Management

The FDA voted to recommend a lixisenatide and glargine combination drug at the Endocrinologic and Metabolic Drugs Advisory Committee meeting.

FDA Advisory Panel Favors Approval of Combination Insulin Degludec/Liraglutide

FDA Advisory Panel Favors Approval of Combination Insulin Degludec/Liraglutide

In a unanimous vote, the advisory committee recommended that the FDA approve combination degludec/liraglutide for type 2 diabetes.

Type 2 Diabetes Risk Up in Highly Deprived Neighborhoods

Type 2 Diabetes Risk Up in Highly Deprived Neighborhoods

Risk may be increased by 22% for people living in high-deprivation areas.

SGLT2 Inhibitors: A Class Effect?

SGLT2 Inhibitors: A Class Effect?

Data on cardiovascular benefits as well as adverse effects have thrust this class of diabetes drugs into the spotlight.

Life Expectancy Gap Between Patients With Type 1 Diabetes and General Population Persists

Life Expectancy Gap Between Patients With Type 1 Diabetes and General Population Persists

Patients with diabetes not only had shorter life expectancy but also lived with disabilities longer than the general population.

Commonly Used Diabetes Drug May Cut Cancer Mortality in Older Women

Commonly Used Diabetes Drug May Cut Cancer Mortality in Older Women

Women with diabetes had a significantly increased risk for dying from cancer, but those taking metformin experienced a survival benefit.

Minding the Gap: From Idea to Innovation in Diabetes

Minding the Gap: From Idea to Innovation in Diabetes

Researchers and clinicians must work to adopt strategies to integrate findings from clinical research into patient care.

ADA Addresses Diabetes Management in Long-Term Care Facilities

ADA Addresses Diabetes Management in Long-Term Care Facilities

Minimizing risks, flexibility, and honoring a patient's wishes are major components of the guidelines.

Physical Activity Deficiency: A New Risk Factor for Type 2 Diabetes?

Physical Activity Deficiency: A New Risk Factor for Type 2 Diabetes?

Sedentary behaviors may boost risk for type 2 diabetes by 22% and risk for metabolic syndrome by 39%.

AACE Issues Consensus Statement on Outpatient Glucose Monitoring in Diabetes

AACE Issues Consensus Statement on Outpatient Glucose Monitoring in Diabetes

The new consensus statement reflects the advances made in glucose monitoring technology and offers guidance for clinicians.

Can Low Resistance to Stress Raise Type 2 Diabetes Risk?

Can Low Resistance to Stress Raise Type 2 Diabetes Risk?

People who are less resilient to stress may face a significantly increased risk for type 2 diabetes later in life.

AACE/ACE Updates Algorithm for Type 2 Diabetes Management

AACE/ACE Updates Algorithm for Type 2 Diabetes Management

The American Association of Clinical Endocrinologists' updated algorithm for type 2 diabetes management addresses lifestyle modifications and obesity treatments.

ADA Includes Significant Updates in 2016 Standards of Medical Care in Diabetes

ADA Includes Significant Updates in 2016 Standards of Medical Care in Diabetes

The American Diabetes Association 2016 Standards of Medical Care in Diabetes address obesity management, heart disease, and vulnerable populations.

PDE-5 Inhibitors May Improve Insulin Sensitivity in Patients at High Risk for Diabetes

PDE-5 Inhibitors May Improve Insulin Sensitivity in Patients at High Risk for Diabetes

A phosphodiesterone 5 inhibitor may improve metabolic parameters that predispose people to developing diabetes.

Meta-Analysis Compares Cardiometabolic Effects, Safety of Once-Weekly GLP-1 Receptor Agonists

Meta-Analysis Compares Cardiometabolic Effects, Safety of Once-Weekly GLP-1 Receptor Agonists

A new review highlights a few differences among various once-weekly GLP-1 receptor agonists.

New IDF Diabetes Atlas: A 'Wake-Up Call' for Endocrinologists?

New IDF Diabetes Atlas: A 'Wake-Up Call' for Endocrinologists?

The United States appears to have the highest prevalence of diabetes compared with other developed nations.

Clinicians Express Concern About New USPSTF Diabetes Screening Recommendations

Clinicians Express Concern About New USPSTF Diabetes Screening Recommendations

Experts contend that the U.S. Preventive Services Task Force new screening recommendations may lead to more cases of undiagnosed diabetes

Insulin Pumps Improve Blood Glucose Control in Children with Type 1 Diabetes

Insulin Pumps Improve Blood Glucose Control in Children with Type 1 Diabetes

An analysis of 3 diabetes registries examines the benefits of using insulin pump therapy in children and adolescents with type 1 diabetes.

AACE/ACE Panel Supports Continued Use of SGLT2 Inhibitors in Diabetes

AACE/ACE Panel Supports Continued Use of SGLT2 Inhibitors in Diabetes

Expert panel recommends continued use of SGLT2 inhibitors, as risk for DKA is low.

Can Marijuana Use Increase Prediabetes Risk?

Can Marijuana Use Increase Prediabetes Risk?

Current, former marijuana users more likely to develop prediabetes but not type 2 diabetes.

Task Force: Diet and Exercise Programs Work for Prediabetes

Task Force: Diet and Exercise Programs Work for Prediabetes

Recommendations made based on 53 studies on 66 diet and exercise programs.

Hypoglycemia in an Outpatient Office Setting

Hypoglycemia in an Outpatient Office Setting

A type 1 diabetes patient presents to an outpatient facility agitated and slurring his words. Emergency medical help was called to assist the patient.

Eating Disorders Relatively Common in Diabetes

Eating Disorders Relatively Common in Diabetes

Disordered eating behaviors more common in diabetes than in the general population.

Reviewing Reports of Ketoacidosis With SGLT2 Inhibitors

Reviewing Reports of Ketoacidosis With SGLT2 Inhibitors

Jennifer N. Clements, PharmD, BPCS, CDE, BCACP, reviews some details of the reports of ketocacidosis with the use of SGLT2 inhibitors.

Can Gene Therapy Reverse Diabetic Neuropathy?

Can Gene Therapy Reverse Diabetic Neuropathy?

A plasmid containing two human hepatocyte growth factor isoforms may improve quality of life for patients with painful diabetic neuropathy.

Combating the Global Epidemics of Diabetes, Tuberculosis

Combating the Global Epidemics of Diabetes, Tuberculosis

Greater efforts are needed to address the growing burden of tuberculosis and diabetes in developing countries.

The Growing Problem of Peripheral Neuropathy in Prediabetes

The Growing Problem of Peripheral Neuropathy in Prediabetes

Early intervention is essential to treating neuropathy in those with prediabetes.

Ramadan and Diabetes: Medical Challenges, Concerns and Considerations

Ramadan and Diabetes: Medical Challenges, Concerns and Considerations

Individualization is key to diabetes management during Ramadan, a month of fasting, for patients who follow Islam.

Transplant in Type 2 Diabetes: Inpatient and Outpatient Management

Transplant in Type 2 Diabetes: Inpatient and Outpatient Management

A patient, aged 60 years, was admitted to the hospital to undergo renal transplant therapy. He had a history of type 2 diabetes for 15 years.

Pramlintide: Where Does It Fit into Diabetes Care?

Pramlintide: Where Does It Fit into Diabetes Care?

Reflections on the drug may raise questions about when to use pramlintide in diabetes.

Reviewing Role of Vitamin D in Endocrine Disorders

Reviewing Role of Vitamin D in Endocrine Disorders

In addition to bone health, it now appears that vitamin D plays a major role in preventing inflammation that leads to type 2 diabetes and atherosclerosis.

New AACE/ACE Diabetes Guidelines Go Beyond Glycemic Control

New AACE/ACE Diabetes Guidelines Go Beyond Glycemic Control

The new AACE clinical practice guidelines for diabetes and updated diabetes algorithm advocate a comprehensive approach to managing diabetes.

A Call for Improved Surveillance of Insulin Pump Therapy

A Call for Improved Surveillance of Insulin Pump Therapy

Experts are now calling for a more standardized and transparent approach to identifying and reporting adverse events with insulin pump therapy.

Screening Asymptomatic Adults for Type 2 Diabetes May Not Improve Mortality

Screening Asymptomatic Adults for Type 2 Diabetes May Not Improve Mortality

A new systematic review has found that screening for type 2 diabetes does not appear to affect mortality, but it may delay progression to the disease.

Can Diabetes Damage the Brain?

Can Diabetes Damage the Brain?

Prolonged exposure to hyperglycemia may have measurable effects on the brain that make patients with diabetes more prone to developing dementia or cognitive impairment.

Hospital-to-Home Transition of Type 2 Diabetes Patient With Complex Insulin Regimen

Hospital-to-Home Transition of Type 2 Diabetes Patient With Complex Insulin Regimen

When creating outpatient diabetes management plan, the patient's inpatient medication regimen should be considered but not necessarily replicated.

Foot Inflammation in Type 2 Diabetes

Foot Inflammation in Type 2 Diabetes

A patient diagnosed with type 2 diabetes, hypertension, hyperlipidemia presents to the foot clinic after 1 month of swelling, redness, and warmth in the left foot.

Acarbose May Pose Higher Cardiovascular Risk Than Metformin

Acarbose May Pose Higher Cardiovascular Risk Than Metformin

Robert W Lash, MD, of the Endocrine Society, finds this study interesting and useful, but not a stinging indictment of acarbose.

New Year, New Recommendations for Diabetes Care

New Year, New Recommendations for Diabetes Care

A new ADA and EASD position statement along with the ADA's revised Standards of Medical Care in Diabetes have surprising updates.

Continuous Blood Glucose Monitoring in Newly Diagnosed Type 1 Diabetes

Continuous Blood Glucose Monitoring in Newly Diagnosed Type 1 Diabetes

A 25-year-old woman newly diagnosed with type 1 diabetes presents with insidious onset of recurrent hypoglycemia and is given a CGM device.

Life Expectancy in Type 1 Diabetes

Life Expectancy in Type 1 Diabetes

Life expectancy appears to be shorter in type 1 diabetes, but intensive glycemic therapy has been linked to lower mortality rates.

Revised ADA Standards Allow Personalized Approach to Diabetes Treatment

Revised ADA Standards Allow Personalized Approach to Diabetes Treatment

New HbA1c targets, recommendations on statin therapy and blood pressure goals are included in the revised ADA's Standards of Care.

Adopting a 'Cascade of Care' Approach to Diabetes

Adopting a 'Cascade of Care' Approach to Diabetes

Adopting a new approach to diabetes may help identify patients who have so far gone undiagnosed.

Postponement of Surgery in a Man With Type 2 Diabetes

Postponement of Surgery in a Man With Type 2 Diabetes

After a patient's elective surgery was postponed due to glucose readings, an assessment of his medical profile and history were evaluated to manage his type 2 diabetes mellitus complications.

Diabetes Drugs: Does Class Matter?

Diabetes Drugs: Does Class Matter?

Experts discuss the use of newly approved agents, such as DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors, for type 2 diabetes.

Considering Qsymia for Obese Patients With Type 2 Diabetes

Considering Qsymia for Obese Patients With Type 2 Diabetes

Evidence shows that the maximum dose of Qsymia is effective for obese patients with type 2 diabetes, but clinicians should still consider all factors.

Diabetes Management in Childcare Settings

Diabetes Management in Childcare Settings

Careful consideration of unique issues and a coordinated team effort is necessary to providing optimal care for children with diabetes in childcare settings.

Reevaluating Cardiovascular Safety Requirements for Diabetes Drugs

Reevaluating Cardiovascular Safety Requirements for Diabetes Drugs

Large cardiovascular outcomes trials may not be necessary to assess safety of all diabetes drugs.

A Closer Look at Glucose Monitoring Technologies

A Closer Look at Glucose Monitoring Technologies

Accuracy of glucose monitoring systems remains an issue of concern, but new technologies are on the horizon.

Untreated Diabetes, Osteoporosis Worsened by Environmental Exposures

Untreated Diabetes, Osteoporosis Worsened by Environmental Exposures

Heavy metal exposure from a patient's well water accelerated multisystem damage associated with diabetes.

Education Can Diminish Blow of Diabetes Diagnosis

Education Can Diminish Blow of Diabetes Diagnosis

Help patients direct their energy into positive behaviors to manage their diabetes.

Misdiagnosis of Latent Autoimmune Diabetes of Adulthood

Misdiagnosis of Latent Autoimmune Diabetes of Adulthood

Despite adhering to lifestyle modifications, a woman's glycemic control remains inadequate.

Sign Up for Free e-Newsletters

CME Focus